Cargando…
A potent HNF4α agonist reveals that HNF4α controls genes important in inflammatory bowel disease and Paneth cells
HNF4α has been implicated in IBD through a number of genome-wide association studies. Recently, we developed potent HNF4α agonists, including N-trans caffeoyltyramine (NCT). NCT was identified by structural similarity to previously the previously identified but weak HNF4α agonists alverine and benfl...
Autores principales: | Lee, Seung-Hee, Veeriah, Vimal, Levine, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985954/ https://www.ncbi.nlm.nih.gov/pubmed/35385524 http://dx.doi.org/10.1371/journal.pone.0266066 |
Ejemplares similares
-
Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist
por: Lee, Seung-Hee, et al.
Publicado: (2021) -
Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function
por: Veeriah, Vimal, et al.
Publicado: (2022) -
HNF4α Acts as Upstream Functional Regulator of Intestinal Wnt3 and Paneth Cell Fate
por: Jones, Christine, et al.
Publicado: (2022) -
Epistasis of Transcriptomes Reveals Synergism between Transcriptional Activators Hnf1α and Hnf4α
por: Boj, Sylvia F., et al.
Publicado: (2010) -
Crystallization of hepatocyte nuclear factor 4α (HNF4α) in complex with the HNF1α promoter element
por: Lu, Peng, et al.
Publicado: (2008)